Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William H. Tomaszewski, Luis Sánchez-Pérez, Thomas F. Gajewski, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 14, pp. 4202-4210
Open Access | Times Cited: 270

Showing 1-25 of 270 citing articles:

Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson, John Choi, Michael Lim
Nature Immunology (2019) Vol. 20, Iss. 9, pp. 1100-1109
Closed Access | Times Cited: 581
Meningeal lymphatic vessels regulate brain tumor drainage and immunity
Xueting Hu, Qiuping Deng, Lu Ma, et al.
Cell Research (2020) Vol. 30, Iss. 3, pp. 229-243
Open Access | Times Cited: 279
Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial
E. Antonio Chiocca, John S. Yu, Rimas V. Lukas, et al.
Science Translational Medicine (2019) Vol. 11, Iss. 505
Open Access | Times Cited: 218
Circulating biomarkers in patients with glioblastoma
Juliana Müller Bark, Arutha Kulasinghe, Benjamin Chua, et al.
British Journal of Cancer (2019) Vol. 122, Iss. 3, pp. 295-305
Open Access | Times Cited: 210
CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
Michael C. Burger, Congcong Zhang, Patrick N. Harter, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 176
The Evolving Role of CD8+CD28− Immunosenescent T Cells in Cancer Immunology
Wei Huff, Jae Hyun Kwon, Mario Henriquez, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 11, pp. 2810-2810
Open Access | Times Cited: 165
Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology
Aline Paixão Becker, Blake Sells, Shagufta Haque, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 761-761
Open Access | Times Cited: 126
CXCL11-armed oncolytic adenoviruses enhance CAR-T cell therapeutic efficacy and reprogram tumor microenvironment in glioblastoma
Guoqing Wang, Zongliang Zhang, Kunhong Zhong, et al.
Molecular Therapy (2022) Vol. 31, Iss. 1, pp. 134-153
Open Access | Times Cited: 116
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar, et al.
Nature (2023) Vol. 623, Iss. 7985, pp. 157-166
Open Access | Times Cited: 109
Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma
Dongjiang Chen, Son B Le, Tarun E. Hutchinson, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 8
Open Access | Times Cited: 91
Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities
Guoqing Wang, Kunhong Zhong, Zeng Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 86
Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
Nan Zhang, Hao Zhang, Wantao Wu, et al.
Theranostics (2022) Vol. 12, Iss. 13, pp. 5931-5948
Open Access | Times Cited: 84
Recurrent Glioblastoma: A Review of the Treatment Options
Maria Angeles Vaz-Salgado, María Villamayor, Víctor Albarrán, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4279-4279
Open Access | Times Cited: 49
Macrophages in Recurrent Glioblastoma as a Prognostic Factor in the Synergistic System of the Tumor Microenvironment
Nicola Montemurro, Bhavya Pahwa, Anish Tayal, et al.
Neurology International (2023) Vol. 15, Iss. 2, pp. 595-608
Open Access | Times Cited: 42
Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
Justin Low, Michael C. Brown, Zachary J. Reitman, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 17
Myeloid Cells in Glioblastoma Microenvironment
Alessandra De Leo, Alessio Ugolini, Filippo Veglia
Cells (2020) Vol. 10, Iss. 1, pp. 18-18
Open Access | Times Cited: 115
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi, Na Guo, Jing Luan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 108
Immunocytokines are a promising immunotherapeutic approach against glioblastoma
Tobias Weiß, Emanuele Puca, Manuela Silginer, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 564
Closed Access | Times Cited: 101
Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
K. Jason, Nakho Chang, Hye Won Lee, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 91
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 89
Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
Yang Xun, Hua Yang, Bożena Kamińska, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 85
Arginase-1+ Exosomes from Reprogrammed Macrophages Promote Glioblastoma Progression
Juliana H. Azambuja, Nils Ludwig, Saigopalakrishna S. Yerneni, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3990-3990
Open Access | Times Cited: 82
Role of Neutrophils and Myeloid-Derived Suppressor Cells in Glioma Progression and Treatment Resistance
Sabbir Khan, Sandeep Mittal, Kain McGee, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 6, pp. 1954-1954
Open Access | Times Cited: 79
Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma
Jason Miska, Aida Rashidi, Catalina Lee-Chang, et al.
Science Advances (2021) Vol. 7, Iss. 8
Open Access | Times Cited: 79
Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma
Apeng Chen, Yinan Jiang, Zhengwei Li, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 16
Open Access | Times Cited: 76
Page 1 - Next Page

Scroll to top